Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Core Trust Seal
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Thursday, 29 January 2015

Latest study confirms further spread and emergence of antimalarial resistance in Southeast Asia

The latest study published in the New England Journal of Medicine, confirms that resistance to the current frontline antimalarial, artemisinin, is now present in Eastern Myanmar, Thailand and Southern Vietnam, as well as Western Cambodia.
Thursday, 29 January 2015

Revealing molecular strategies to preserve drug efficacy

Thursday, 29 January 2015

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Thursday, 29 January 2015

New African Network exploring diversity of malaria

Thursday, 29 January 2015

Join us at 6th MIM Pan-African Malaria Conference in Durban, South Africa

Thursday, 29 January 2015

WHO put the spotlight on artemisinin resistance

Thursday, 29 January 2015

WHO call for urgent action to reduce monotherapies

Thursday, 29 January 2015

MIM release final symposium programme

Thursday, 29 January 2015

US Government Releases Sixth Annual Malaria Report

Thursday, 29 January 2015

Older tourists at risk from malaria

Thursday, 29 January 2015

RBM appoints Executive Director

Thursday, 29 January 2015

Pyronaridine/artesunate included in the list of WHO prequalified medicines

Thursday, 29 January 2015

Artemisinin resistance on the Thai-Myanmar border

Thursday, 29 January 2015

Malaria genome sequences reveal new drug challenges

Thursday, 29 January 2015

Text messaging can help control malaria

Thursday, 29 January 2015

WHO prequalifies new ACT

Thursday, 29 January 2015

Eastern African scientists pledge to confront the threat of malaria drug resistance

Thursday, 29 January 2015

Global Fund forecasts $1.6 billion in available funds for 2012-2014

Thursday, 29 January 2015

Global Fund Board launches new funding approach and approves first grants

Thursday, 29 January 2015

WWARN supports World Malaria Day

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Current page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • …
  • Next page ››
  • Last page Last »

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2026 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use